These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

85 related items for PubMed ID: 11535970

  • 1. Oral neltenexine in patients with obstructive airways diseases: an open, randomised, controlled comparison versus sobrerol.
    Fadda G.
    Minerva Med; 2001 Aug; 92(4):269-75. PubMed ID: 11535970
    [Abstract] [Full Text] [Related]

  • 2. Neltenexine tablets in smoking and non-smoking patients with COPD. A double-blind, randomised, controlled study versus placebo.
    Cattaneo C.
    Minerva Med; 2001 Aug; 92(4):277-84. PubMed ID: 11535971
    [Abstract] [Full Text] [Related]

  • 3. [The effect of inhaled ambroxol treatment on clinical symptoms and chosen parameters of ventilation in patients with exacerbation of chronic obstructive pulmonary disease patients].
    Jahnz-Rózyk K, Kucharczyk A, Chciałowski A, Płusa T.
    Pol Merkur Lekarski; 2001 Sep; 11(63):239-43. PubMed ID: 11761819
    [Abstract] [Full Text] [Related]

  • 4. No demonstrable effect of sobrerol as an expectorant in patients with stable chronic bronchial diseases.
    Medici TC, Shang H, Grosgurin P, Berg P, Achermann R, Wehrli R.
    Bull Eur Physiopathol Respir; 1985 Sep; 21(6):477-83. PubMed ID: 3907738
    [Abstract] [Full Text] [Related]

  • 5. [Effect of mucolytic therapy on the production of reactive oxygen species in the blood of patients with an exacerbation of chronic obstructive pulmonary disease].
    Farkhutdinov UR, Farkhutdinov RR, Petriakov VV, Farkhutdinov ShU, Mirkhaĭdarov AM.
    Ter Arkh; 2010 Sep; 82(3):29-32. PubMed ID: 20564918
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Mucolytic agents. Polycentric study of a carbocysteine-sobrerol combination].
    Gramiccioni E, Pamparana F, Messa A.
    Arch Monaldi Mal Torace; 1989 Sep; 44(4-6):791-3. PubMed ID: 2577796
    [No Abstract] [Full Text] [Related]

  • 8. [A controlled study on the action of a new formulation of ambroxol in asthmatiform bronchitis in children].
    Baldini G, Gucci M, Tarò D, Memmini C.
    Minerva Pediatr; 1989 Feb; 41(2):91-5. PubMed ID: 2661989
    [Abstract] [Full Text] [Related]

  • 9. Effectiveness of erdosteine in elderly patients with bronchiectasis and hypersecretion: a 15-day, prospective, parallel, open-label, pilot study.
    Crisafulli E, Coletti O, Costi S, Zanasi E, Lorenzi C, Lucic S, Fabbri LM, Bertini M, Clini EM.
    Clin Ther; 2007 Sep; 29(9):2001-9. PubMed ID: 18035199
    [Abstract] [Full Text] [Related]

  • 10. Intravenous aminophylline in patients admitted to hospital with non-acidotic exacerbations of chronic obstructive pulmonary disease: a prospective randomised controlled trial.
    Duffy N, Walker P, Diamantea F, Calverley PM, Davies L.
    Thorax; 2005 Sep; 60(9):713-7. PubMed ID: 15939732
    [Abstract] [Full Text] [Related]

  • 11. Plant-based formulation in the management of chronic obstructive pulmonary disease: a randomized double-blind study.
    Murali PM, Rajasekaran S, Paramesh P, Krishnarajasekar OR, Vasudevan S, Nalini K, Lakshmisubramanian S, Deivanayagam CN.
    Respir Med; 2006 Jan; 100(1):39-45. PubMed ID: 15905081
    [Abstract] [Full Text] [Related]

  • 12. Review on sobrerol as a muco-modifying drug: experimental data and clinical findings in hypersecretory bronchopulmonary diseases.
    Braga PC, Allegra L, Bossi R, Scuri R, Castiglioni CL, Romandini S.
    Int J Clin Pharmacol Res; 1987 Jan; 7(5):381-400. PubMed ID: 3312046
    [Abstract] [Full Text] [Related]

  • 13. [Sobrerol as expectorant in patients with stable chronic respiratory tract infections. A controlled study].
    Shang H, Grosgurin P, Medici TC.
    Schweiz Med Wochenschr; 1982 Dec 11; 112(50):1846-8. PubMed ID: 6760390
    [Abstract] [Full Text] [Related]

  • 14. Neltenexine: morphological investigation of protection against elastase-induced emphysema in rats.
    Braga PC, Piatti G, Limoli A, Dal Sasso M, Maci S.
    Drugs Exp Clin Res; 1995 Dec 11; 21(2):51-7. PubMed ID: 7555609
    [Abstract] [Full Text] [Related]

  • 15. [Clinical evaluation of efficacy and tolerance of oral treatment with ambroxol in patients with chronic bronchitis].
    Michnar M, Milanowski J.
    Pneumonol Alergol Pol; 1996 Dec 11; 64 Suppl 1():90-6. PubMed ID: 9190245
    [Abstract] [Full Text] [Related]

  • 16. Antiinflammatory properties of ambroxol.
    Beeh KM, Beier J, Esperester A, Paul LD.
    Eur J Med Res; 2008 Dec 03; 13(12):557-62. PubMed ID: 19073395
    [Abstract] [Full Text] [Related]

  • 17. Benefits and risks of adjunctive inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis.
    Sobieraj DM, White CM, Coleman CI.
    Clin Ther; 2008 Aug 03; 30(8):1416-25. PubMed ID: 18803985
    [Abstract] [Full Text] [Related]

  • 18. Influence of mucolytic therapy on respiratory mechanics in patients with chronic obstructive pulmonary disease.
    Schreiber J, Bohnsteen B, Rosahl W.
    Eur J Med Res; 2002 Mar 28; 7(3):98-102. PubMed ID: 11953279
    [Abstract] [Full Text] [Related]

  • 19. Open-label study of mirtazapine orally disintegrating tablets in depressed patients in the nursing home.
    Roose SP, Nelson JC, Salzman C, Hollander SB, Rodrigues H, Mirtazapine in the Nursing Home Study Group.
    Curr Med Res Opin; 2003 Mar 28; 19(8):737-46. PubMed ID: 14687445
    [Abstract] [Full Text] [Related]

  • 20. Efficacy and tolerability of sustained-release tramadol in the treatment of symptomatic osteoarthritis of the hip or knee: a multicenter, randomized, double-blind, placebo-controlled study.
    Malonne H, Coffiner M, Sonet B, Sereno A, Vanderbist F.
    Clin Ther; 2004 Nov 28; 26(11):1774-82. PubMed ID: 15639689
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.